The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin
Zaid H. Maayah, Shingo Takahara, Jason R.B. Dyck
Topics & Concepts
CardiotoxicityInflammasomeDoxorubicinPharmacologyCancerAnthracyclineMedicineCancer researchCancer cellChemistryReceptorChemotherapyBreast cancerInternal medicineChemotherapy-induced cardiotoxicity and mitigationDiamond and Carbon-based Materials ResearchPeptidase Inhibition and Analysis